Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Child's Adipose Cells: Capacity of Tissue Regeneration (cicASChild)

10 maj 2017 uppdaterad av: University Hospital, Toulouse

Evaluation of Tissue Regeneration Potential (in the Skin) of Child's Adipose Cells During the Development.

The beneficial effect related to the administration of adipose tissue-derived stromal cells (ADSC) is demonstrated in various situations of physiological and pathological wound healing, thus opening a new field for cell therapy. Despite the use of new technologies, management of burns in children as well as congenital malformation such as hypospadias and cleft lip and/ or cleft palate can lead to aesthetic and functional sequelae requiring multiple surgical procedures. Cell therapy based on the administration of the ADSC seems a promising issue in such indications, however, to date no study has been conducted with ADSC from a pediatric population. An initial study (Protocol 0808203) allowed investigors to obtain the first samples of adipose tissue from children and to conduct an in vitro comparative study on the characterization and properties of the ADSC from children compared to adults. In the continuity, this second study aims to complete knowledge on the efficacy and safety of children ADSC cell therapy assessed in an animal model of skin wound healing developed in the lab.

Studieöversikt

Status

Avslutad

Betingelser

Intervention / Behandling

Detaljerad beskrivning

Through this study, the medium term objective is to approach a clinical protocol for treatment of pathological scars in developing an appropriate way to deliver ADSC for a future clinical application, while ensuring the safety of such procedure.

The primary goal of this work is to determine whether ADSC from children prepared according to Good Manufacturing Practice (GMP), is associated with an improvement of wound healing in vivo as demonstrated with adult ADSC. To answer this question, 40 samples of adipose tissue of children obtained from settled surgery (inguinal hernia and vesico-ureteral reflux by suprapubic way) will be performed within the 2 groups of children; 0 to 1 year and 2 to 13 years, defined from data acquired in the previous protocol. Wound healing will be evaluated in a nude mouse model of skin burn. A macroscopic analysis will be carried out with two indexes described in the literature (re-epithelialization and scar contraction) and expressed as a percentage of the initial lesion at different times (3 days, 7 days, 10 days, 14 days, 21 days, 30 days). A microscopic analysis will be conducted to determine the rate of re-epithelialization (day 7) and the evolution of the skin structural parameters (dermal and epidermal thickness, density of collagen, inflammatory infiltration). These indexes will be defined in the treated group (burned mice and injected with pediatric ADSC) from control mice (burned but not injected with cells). A comparative analysis between the two groups of age will be conducted that will be also compared to data collected with adult ADSC.

To answer to the second part of this primary goal regarding to safety, the study will perform a long-term follow-up (1 yr) of burned mice injected with of ADSC, to obtain data in the animal after transplantation of cells and for further clinical study.

Complementary in vitro investigations still seems necessary to better understand the specificities of ADSC from pediatric origin and particularly to perform transcriptomic and epigenetic studies.

Studietyp

Interventionell

Inskrivning (Faktisk)

38

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Toulouse, Frankrike, 31059
        • CHU de Toulouse-Purpan

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

8 månader till 10 år (Barn)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

INCLUSION CRITERIA:

  • absence of tumor pathology, known systemic or chronic viral
  • absence of long-term treatment
  • signing informed consent form of persons exercising parental authority

    1st group (20 children):

  • Between 0 and less than or equal to 1 year
  • Weighing at least 1500 g at birth
  • Age ≥ 37 weeks of amenorrhea

    2nd group (20 children)

  • Older than 1 year to 10 years

EXCLUSION CRITERIA:

  • Children whose age is above 10 years
  • premature babies with birth weight under 1500 grams
  • Any child with a tumor pathology, a systemic disease, or whose serology (viral) would be known as positive (HIV 1 and 2, hepatitis B, C, ...).
  • Any child following a long term treatment.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Grundläggande vetenskap
  • Tilldelning: Icke-randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Övrig: 0-1 year old child
Adipose tissue sample in 0-1 year old child with an act of surgery settled by cure of inguinal hernia, or by vesico-ureteral ebb by abdominal way
adipose tissue sample
Övrig: >1-10 year old child
Adipose tissue sample in >1-10 year old child with an act of surgery settled by cure of inguinal hernia, or by vesico-ureteral ebb by abdominal way
adipose tissue sample

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Efficacity of treatment as assessed by surface healed skin (cm2) in animal model
Tidsram: 1 month after injection
Efficacy of ADSC in animal model healing
1 month after injection
Efficacity of treatment as assessed by surface healed skin (cm2) in animal model
Tidsram: 1 year after injection
Efficacy of ADSC in animal model healing
1 year after injection
Security as assessed by absence of tumorigenicity at injection site in animal model
Tidsram: 1 month after injection
Clinical security of treatment
1 month after injection
Security as assessed by absence of tumorigenicity at injection site in animal model
Tidsram: 1 year after injection
Clinical security of treatment
1 year after injection

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Philippe GALINIER, MD, PhD, Chirurgie pédiatrique - Hôpital des enfants

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 januari 2012

Primärt slutförande (Faktisk)

1 januari 2015

Avslutad studie (Faktisk)

1 januari 2015

Studieregistreringsdatum

Först inskickad

10 juli 2015

Först inskickad som uppfyllde QC-kriterierna

17 maj 2016

Första postat (Uppskatta)

20 maj 2016

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

12 maj 2017

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

10 maj 2017

Senast verifierad

1 maj 2017

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • 11 228 02
  • 2011-A01469-32 (Registeridentifierare: Agence National du Médicament et des Produits de santé)

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Brännskador

Kliniska prövningar på adipose tissue sample

3
Prenumerera